MedTrace Logo

Automated Diagnostic Performance of Smartwatch ECG for Arrhythmia Detection Using the PulseAI Neural Network.

NCT05668377 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-12-29

No results posted yet for this study

Summary

The study is to evaluate the performance of the PulseAI neural network technology at interpreting ECG data recorded using a single-lead Smartwatch (Apple Watch).

Conditions

  • Arrhythmias, Cardiac

Interventions

DEVICE

PulseAI ECG Platform

Cloud-based AI-enabled ECG analysis platform

Sponsors & Collaborators

  • Beacon Hospital Research Institute, Dublin, Ireland

    collaborator UNKNOWN

  • PulseAI Ltd

    lead INDUSTRY

Principal Investigators

  • David Burke, PhD · Beacon Hospital Research Institute, Dublin

Eligibility

Min Age
22 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2024-01-01
FDA Device
Yes

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05668377 on ClinicalTrials.gov